Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1985;72:1148-1154

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Criley, J. M.
Right arrow Articles by Siegel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Criley, J. M.
Right arrow Articles by Siegel, R. J.

Circulation, Vol 72, 1148-1154, Copyright © 1985 by American Heart Association


ARTICLES

Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?

JM Criley and RJ Siegel

HCM is a disorder associated with significant morbidity and mortality and a propensity to cause sudden, often unexpected death. The similarity to the symptom complex of aortic stenosis and the presence of a pressure gradient justified the initial assumption that obstruction was of prime importance in HCM and that relief of obstruction was the focal point of rational therapy. However, it is our belief that the dogma of obstruction has impeded progress in and obscured the understanding of HCM and interpretation of its manifestations. The purpose of this article is to call attention to significant discrepancies in the obstructive concept that have been reinforced as new techniques emerged that have allowed further study of the disease. Since neither the presence of a gradient nor SAM can be justifiably equated with the presence of an obstruction, it is proposed that the appellation "obstruction" be reserved for those cases in which the rate of outflow or the rate or degree of ventricular emptying are demonstrably impeded, as in aortic stenosis. Therapy with beta- adrenergic-receptor and calcium channel-blocking agents have shown promise for alleviating symptoms and possibly prolonging life without systematically or predictably affecting the pressure gradient, probably because of their beneficial effects on ventricular relaxation and diastolic filling. Antiarrhythmic therapy has been effective in reducing mortality. Ideally, prevention or regression of the pathologic hypertrophy should be the major focus of future therapeutic interventions in hypertrophic cardiomyopathy.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. J. Maron, M. S. Maron, E. D. Wigle, and E. Braunwald
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
J. Am. Coll. Cardiol., July 14, 2009; 54(3): 191 - 200.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S R Ommen, P M Shah, and A J Tajik
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
Heart, October 1, 2008; 94(10): 1276 - 1281.
[Full Text] [PDF]


Home page
CirculationHome page
R. A. Nishimura and S. R. Ommen
Hypertrophic Cardiomyopathy: The Search for Obstruction
Circulation, November 21, 2006; 114(21): 2200 - 2202.
[Full Text] [PDF]


Home page
NEJMHome page
M. S. Maron, I. Olivotto, S. Betocchi, S. A. Casey, J. R. Lesser, M. A. Losi, F. Cecchi, and B. J. Maron
Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
N. Engl. J. Med., January 23, 2003; 348(4): 295 - 303.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W.J. Paulus
Natriuretic peptides to probe haemodynamic overload in hypertrophic cardiomyopathy
Eur. Heart J., August 1, 2001; 22(15): 1249 - 1251.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Ommen, R. A. Nishimura, R. W. Squires, H. V. Schaff, G. K. Danielson, and A. J. Tajik
Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points
J. Am. Coll. Cardiol., July 1, 1999; 34(1): 191 - 196.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Kizilbash, S. K. Heinle, and P. A. Grayburn
Spontaneous Variability of Left Ventricular Outflow Tract Gradient in Hypertrophic Obstructive Cardiomyopathy
Circulation, February 10, 1998; 97(5): 461 - 466.
[Abstract] [Full Text] [PDF]